Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

AGM Statement

28 Jul 2009 07:00

RNS Number : 3620W
Imaginatik PLC
28 July 2009
Β 

ο»Ώ

28 JulyΒ 2009

ImaginatikΒ plc

("Imaginatik" or the "Company")

AGM Statement

Howard Marshall, ChairmanΒ of Imaginatik plc (AIM: IMTK), a leading provider ofΒ enterpriseΒ collaborative software and processes,Β will make the following statement at the Company'sΒ Annual General Meeting to be held laterΒ today:

"As with last year, the new financial year has started slowlyΒ withΒ prospective clientsΒ continuing to beΒ cautious in their commitment to spend.Β However, we are pleased to announceΒ several good client wins of late through our strategic partnership withΒ HultΒ BusinessΒ School, resulting inΒ ourΒ IdeaΒ Central software being used at Osram Sylvania, Philips Medical Systems, Siemens andΒ BAEΒ Systems amongst others.

Consistent with previous years, we anticipate that the larger part of our revenues will come in the second half of the financial year and, as expected, the Company will incur a loss in the six months toΒ 30 September 2009. Despite the difficult market conditions and economic uncertainties, we still anticipate another year of revenue growth for the Company and continue to remain optimistic in our sales pipeline which is developing well as a result of our increased focus on marketing the Company and our software and services offering."

Β 

For further information please contact:

Imaginatik plc

Tel: 020 7917 2975

Mark Turrell, CEO / Shawn Taylor, CFO

Arbuthnot Securities Limited

Tel: 020 7012 2000

Tom Griffiths

ICIS

Tel: 020 7651 8688

Tom Moriarty / Caroline Evans-Jones

About Imaginatik

Imaginatik isΒ aΒ leading provider of web-basedΒ enterpriseΒ collaboration software. Imaginatik's core software, Idea Central, is designed to help companies focus on idea generation towards strategic business objectives, and to share, develop and review those ideas across the organisation. Some of the world's largestΒ organisations such as Merck, Dow, Chevron, General Electric and CargillΒ use Imaginatik's software, consulting and leading-edge research to enable their best-of-breed innovation, cost-reduction and process improvement activities.

Having been named as a World Economic Forum Technology Pioneer and a finalist for the IBM Lotus Awards in the Best Industry Solution category, Imaginatik's software and consulting services have helped clients discover significant sources of additional revenue, as well as tangible cost savings. Imaginatik is also committed to developing strategic solutions in the field of innovation, working with academic institutions such as theΒ HultΒ BusinessΒ SchoolΒ inΒ Boston, and the Cass School of Business,Β London, as well as leading practitioners of corporate innovation.

For further information please visit http://www.imaginatik.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGMGGGZNNNKGLZM
Date   Source Headline
19th Dec 20083:16 pmRNSDirector/PDMR Shareholding
18th Dec 20089:45 amRNSDirector/PDMR Shareholding
17th Dec 20087:00 amRNSShare Option Schemes
1st Dec 20087:00 amRNSDirector's Disclosure Update
19th Nov 200812:39 pmRNSDirectors Dealing
13th Nov 20087:00 amRNSInterim Results
14th Oct 20087:00 amRNSTrading Statement
2nd Oct 20087:00 amRNSContract Win
30th Sep 20084:30 pmRNSTotal Voting Rights
24th Sep 20087:00 amRNSDirector/PDMR Shareholding
15th Sep 20087:00 amRNSContract Win
3rd Sep 20087:00 amRNSIssue of Equity
21st Aug 20087:00 amRNSContract Win
28th Jul 20089:27 amRNSNon-Executive Retirement
10th Jul 200810:20 amRNSResult of AGM
10th Jul 20087:00 amRNSAGM Statement
24th Jun 20087:00 amRNSDirector/PDMR Shareholding
18th Jun 200810:05 amRNSAnnual Report and Accounts
13th Jun 200812:16 pmRNSDirector/PDMR Shareholding
11th Jun 20087:00 amRNSFinal Results
1st Apr 200811:52 amRNSDirector Dealings
31st Mar 20084:30 pmRNSTotal Voting Rights
17th Mar 20082:57 pmRNSShare Subscription - Update
10th Mar 20082:23 pmRNSShare Subscription
10th Mar 20089:30 amRNSHolding(s) in Company
28th Feb 200810:01 amRNSPfizer Update
13th Feb 20089:40 amRNSTrading Statement
22nd Jan 20089:30 amRNSWorld Economic Forum
11th Jan 200810:13 amRNSMajor Contract Wins
30th Nov 20072:41 pmRNSWEF Technology Pioneer
14th Nov 20072:12 pmRNSInterim Results
16th Aug 200711:05 amRNSAgreement With IBM
14th Aug 20074:55 pmRNSAIM Rule 26 Information
27th Jul 200710:46 amRNSAGM Statement
27th Jul 20077:01 amRNSAGM Statement
11th Jul 200712:00 pmBUSGlobal Competition Forces Innovation and Collaboration Acceleration
29th Jun 20073:33 pmRNSAnnual Report and Accounts
13th Jun 200711:50 amRNSResult of EGM
12th Jun 20077:02 amRNSFinal Results
4th Jun 20077:02 amRNSUK & European Contract Wins
1st Jun 200710:29 amRNSNotice of Results
18th May 200710:05 amRNSNotice of EGM
23rd Apr 20072:38 pmBUSImaginatik Wins a Queens Award for Enterprise
23rd Apr 200711:02 amRNSWins A Queens Award
19th Apr 200710:59 amRNSDirector/PDMR Shareholding
21st Mar 20077:04 amRNSSenior Management Appointment
21st Mar 20077:01 amBUSImaginatik Appoints President, Americas and New CMO to Accommodate Growth
16th Mar 200711:45 amRNSTrading Statement
9th Feb 200711:30 amBUSImaginatik Appoints Managing Director in United Kingdom
9th Feb 20077:00 amRNSAppointment of UK MD

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.